https://www.selleckchem.com/mTOR.html
There are no randomized controlled trials that assess the use of a CO2 vaginal laser in gynecologic cancer patients. The number of published gynecological cancer patients treated with a CO2 laser for the management of GSM is extremely limited (N less then 10. There is a lack of literature on the impact and safety of vaginal CO2 laser use to manage GSM in gynecologic cancer patients. The airway epithelial barrier can be disrupted by house dust mite (HDM) allergens leading to allergic airway inflammation. Zerumbone, a natural monocyclic sesquiter
Like
Comment
Share
